Table 1. Criteria used to define metabolic health status.
Aguilar-Salinas | Karelis | Meigs (A)1 | Meigs (B)2 | Wildman | |
---|---|---|---|---|---|
Blood pressure | SBP <140 and DBP <90 or no treatment | - | SBP ≥130 or DBP ≥85 or treatment | - | SBP ≥130 or DBP ≥85 or treatment |
TAG, mmol/L | - | ≤1.70 | ≥1.70 | - | ≥1.70 |
HDL-C, mmol/L | ≥1.04 | ≥1.30 and no treatment | <1.04 (M) <1.30 (F) | - | <1.04 (M) <1.30 (F) or treatment |
LDL-C, mmol/L | - | ≤2.60 and no treatment | - | - | - |
Total-C, mmol/L | - | ≥5.20 | - | - | - |
FPG, mmol/L | <7.00 and no treatment | - | ≥5.60 or treatment | - | ≥5.55 or treatment |
HOMA | ≤1.95 | <75th percentile3 | >90th percentile | ||
Other | - | - | Waist >102cm (M)Waist >88cm (F) | - | CRP >90th percentile |
MH criteria | All of the above | ≥4 of the above | <3 of the above | All of the above | <2 of the above |
Study population | Mexico n = 716, 26.4% male | Canada n = 154, 0% male | US n = 2902, 45% male | US n = 2902, 45% male | US n = 5440, 47.9% male |
Abbreviations: DBP: diastolic blood pressure; F: female; FPG: fasting plasma glucose; M: male; MH: metabolically healthy; SBP: systolic blood pressure. 1Using metabolic syndrome variables. 2Using homeostasis model only. 3Among non-diabetic subjects.